Impaired Chromatin Transforming Predicts Higher Survival to Modified Gemcitabine and S-1 plus Nivolumab in Superior Biliary Tract Most cancers: A Part II T1219 Examine | Scientific Most cancers Analysis


Quotation

Nai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai, Chin-Fu Hsiao, Chung-Yu Huang, Yi-Ping Hung, Chien-Jui Huang, San-Chi Chen, Yan-Shen Shan, Yee Chao, Yi-Hsiang Huang, I-Cheng Lee, Pei-Chang Lee, Yung-Yeh Su, Shu-Jen Chen, Chun-Nan Yeh, Li-Tzong Chen, Ming-Huang Chen; Impaired Chromatin Transforming Predicts Higher Survival to Modified Gemcitabine and S-1 plus Nivolumab in Superior Biliary Tract Most cancers: A Part II T1219 Examine. Clin Most cancers Res 2022; https://doi.org/10.1158/1078-0432.CCR-22-1152

Obtain quotation file:



Supply hyperlink

Leave a Reply

Your email address will not be published.